(1991) documented that IV infusion of 2 g/m^2 raised plasma glutathione from 17.5 umol/L to 823 umol/L -- a roughly 47-fold increase -- with a half-life of approximately 14 minutes (Aebi et al., 1991)
A large retrospective cohort study published in early 2026 (Barnett et al., Cureus) matched nearly 390,000 diabetic patients on GLP-1 therapy against a similar number not on GLP-1 therapy 4
We were also mindful of sugar each smoothie on the menu contains zero grams of added sugar. The timing of this menu launch aligns with the increasing focus on personalized wellness and nutrition, especially for those incorporating medications into their health journey
Available from: Accessed on 21/012026 Soliman N, Moisset X, Ferraro MC, et al
2.2.3 Comparator(s)/control Other glucose-lowering drugs used to treat type 2 diabetes, such as insulin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, metformin, and thiazolidinediones, will serve as comparators
That's a massive physical transformation, and the body's tissues, particularly the skin, don't always keep pace with the fat loss underneath challenges of major weight loss
